课题基金 / 基金详情

National HIV Behavioral Surveillance System

National HIV Behavioral Surveillance System
国家艾滋病毒行为监测系统
批准号:
8400862
负责人:
TOM JAENICKE
金额:
$44.89万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-01-01 至 2015-12-31

项目摘要

项目成果

TOM JAENICKE的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要 疾病控制和预防中心(CDC)目前正在进行全国艾滋病毒 美国21个大都市统计地区(MSA)的行为监测(NHBS),包括 西雅图海事局。我们建议从2011年到2015年继续在西雅图MSA开展NHBS。这个 NHBS在西雅图MSA的目标是为当地的HIV预防资源提供相关数据 分配和预防方案评估。为达致这个目标,我们建议 与疾控中心合作,继续维护和评估行为监测系统 与男男性行为(MSM)、注射、感染HIV有关的混合感染 吸毒者(IDU)和高危异性恋者(HET)。具体地说,我们将进行 形成性研究和基于社区的调查以及每年的艾滋病毒检测。我们将进行一项 每年进行调查,评估艾滋病毒危险行为、艾滋病毒预防服务的获得和利用情况, 和西雅图地区男男性接触者(2011和2014)、注射吸毒者(2012和2015)和HET中的艾滋病毒流行率 (2014)。我们将与西雅图地区的社区组织、公共卫生组织合作 系同事,华盛顿大学研究人员,在定性和 采用量化方法开展全国健康状况调查并评估和传播结果。我们将聘用 基于地点的时空抽样(VBS)和受访者驱动的抽样(RDS)和完成 对MSM和IDU周期中每个周期500名合格参与者和HET中450名合格参与者进行的调查 周而复始。我们将为所有三个国家的NHBS参与者提供自愿的艾滋病毒咨询和检测 评估艾滋病毒血清阳性率的周期。我们将对NHBS系统进行评估 包括抽样策略和数据收集方法,以确保系统满足其 目标,并为提高质量、效率和有用性提供建议 NHBS在地方和全国都有。我们将合作开发和实施 与西雅图地区社区组织进行的当地预防调查问题 由疾病预防控制中心直接资助,或由国家或地方通过社区规划资助 进程。我们将促进国家数据收集成果,如MMWR报告 和其他出版物,并提供数据传播计划,这将有助于地方和 国家监控报告工作。最后,我们将实施丙型肝炎咨询和 在MSM和IDU周期中进行检测以评估丙型肝炎血清阳性率。西雅图地区 NHBS系统将继续以西雅图和西雅图艾滋病毒/性传播疾病公共卫生计划为基础 国王郡。
英文摘要
Project Summary/Abstract The Centers for Disease Control and Prevention (CDC) currently conducts National HIV Behavioral Surveillance (NHBS) in 21 metropolitan statistical areas (MSA) in the U.S., including the Seattle MSA. We propose to continue NHBS in the Seattle MSA from 2011 to 2015. The goal of NHBS in the Seattle MSA is to provide relevant data for local HIV prevention resource allocation and prevention program evaluation. To accomplish this goal, we propose to collaborate with CDC to continue maintaining and evaluating a surveillance system of behaviors and co-infections related to HIV acquisition in men who have sex with men (MSM), injection drug users (IDU), and heterosexuals at increased risk (HET). Specifically, we will conduct formative research and community-based surveys and HIV testing each year. We will conduct a survey each year to assess HIV risk behaviors, HIV prevention services access and utilization, and HIV prevalence among Seattle-area MSM (2011 and 2014), IDU (2012 and 2015) and HET (2014). We will collaborate with Seattle area community-based organizations, public health department colleagues, University of Washington researchers with expertise in qualitative and quantitative methods to conduct NHBS and evaluate and disseminate results. We will employ venue-based time-space sampling (VBS) and respondent-driven sampling (RDS) and complete surveys with 500 eligible participants in each of the MSM and IDU cycles and 450 in the HET cycle. We will provide voluntary HIV counseling and testing to NHBS participants in all three cycles to assess HIV seroprevalence. We will conduct evaluations of the NHBS system including sampling strategies, and data collection methods to ensure that the system meets its goals, and provide recommendations for improving the quality, efficiency and usefulness of NHBS both locally and nationally. We will collaborate on development and implementation of local prevention survey questions with Seattle area community-based organizations that are directly funded by CDC or funded by state or local funding through the community planning process. We will contribute to the national data collections outcomes such as MMWR reports and other publications, and provide a data dissemination plan that will contribute to local and national surveillance reporting efforts. Finally, we will implement hepatitis C counseling and testing in the MSM and IDU cycles to assess hepatitis C seroprevalence. The Seattle area NHBS system will continue to be based at the HIV/STD Program of Public Health - Seattle & King County.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
National HIV Surveillance System
National HIV Surveillance System
National HIV Behavioral Surveillance System
National HIV Behavioral Surveillance System
国内基金
海外基金
人类免疫缺陷病毒(HIV)总核酸检测试剂盒
HIV相关肺癌免疫微环境中关键免疫细胞亚群的功能特征与调控机制研究
基于深度测序与SNV 芯片的HIV重复感染与毒株重组机制研究
  • 批准号:
    2026JJ81281
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    徐艳
  • 依托单位:
PGT123中和抗体修饰的工程化载肽囊泡疫苗通过诱导CD4+ T细胞极化在抗HIV感染中的应用和机制研究